Matthew K Szot's Insider Trades & SAST Disclosures
Matthew K Szot's most recent trade in Cadrenal Therapeutics Inc was a trade of 50,000 Stock Options done . Disclosure was reported to the exchange on Jan. 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matthew K Szot.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cadrenal Therapeutics Inc | Matthew K. Szot | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 50,000 | 50,000 | - | - | Stock Options | |
| SenesTech Inc | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 12,090 | 12,090 | - | - | Stock Option (right to buy) | |
| Cadrenal Therapeutics Inc | Matthew K. Szot | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 250,000 | 250,000 | - | - | Stock Options | |
| SenesTech Inc | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 39,402 | 39,402 | - | - | Stock Option (right to buy) | |
| NAYA Biosciences | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Cadrenal Therapeutics Inc | Matthew K. Szot | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 50,000 | 500,000 | - | 0 | Common Stock | |
| SenesTech Inc | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 209,025 | 209,025 | - | - | Stock Option (right to buy) | |
| NAYA Biosciences | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 12,454 | 12,454 | - | - | Stock Option | |
| NAYA Biosciences | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 10,250 | 24,701 | - | 0 | Common Stock | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 80,000 | 80,000 | - | - | Stock option (right to buy) | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 7,490 | 138,140 (0%) | 0% | 0 | Common Stock | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 01 Oct 2021 | 1,496 | 130,650 (0%) | 0% | 2.6 | 3,830 | Common Stock |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.63 per share. | 01 Jul 2021 | 1,841 | 132,146 (0%) | 0% | 3.6 | 6,683 | Common Stock |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 1,040 | 133,987 (0%) | 0% | - | Common Stock | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 1,040 | 0 | - | - | Restricted Stock Units | |
| SenesTech Inc | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 66,470 | 66,470 | - | - | Stock Option (right to buy) | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.72 per share. | 01 Apr 2021 | 2,205 | 132,947 (0%) | 0% | 3.7 | 8,203 | Common Stock |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share. | 01 Apr 2021 | 1,039 | 135,152 (0%) | 0% | 3.7 | 3,865 | Common Stock |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 1,039 | 1,040 | - | - | Restricted Stock Units | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. | 01 Jan 2021 | 2,204 | 134,113 (0%) | 0% | 2.9 | 6,458 | Common Stock |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 01 Jan 2021 | 1,039 | 136,317 (0%) | 0% | 2.9 | 3,044 | Common Stock |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2021 | 1,039 | 2,079 | - | - | Restricted Stock Units | |
| NAYA Biosciences | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 2,339 | 2,339 | - | 0 | Common Stock | |
| NAYA Biosciences | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 2,339 | 2,339 | - | - | Stock Option | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 150,000 | 150,000 | - | - | Stock options (right to buy) | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 15,919 | 135,636 (0%) | 0% | 0 | Common Stock | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 01 Oct 2020 | 1,397 | 135,278 (0%) | 0% | 2.4 | 3,367 | Common Stock |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 1,039 | 3,118 | - | - | Restricted Stock Units | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 1,039 | 136,675 (0%) | 0% | 0 | Common Stock | |
| SenesTech Inc | Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2020 | 31,401 | 31,401 | - | - | Stock Option (right to buy) | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.36 per share. | 01 Jul 2020 | 1,701 | 119,717 (0%) | 0% | 2.4 | 4,014 | Common Stock |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 1,039 | 4,157 | - | - | Restricted Stock Units | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 1,039 | 120,408 (0%) | 0% | 0 | Common Stock | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 1,010 | 121,418 (0%) | 0% | 0 | Common Stock | |
| S&W Seed Co | Matthew K. Szot | EVP Finance & Admin and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 1,010 | 0 | - | - | Restricted Stock Units | |
| SenesTech Inc | Matthew K. Szot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2020 | 846 | 4,658 (0%) | 0% | 0 | Common Stock | |
| SenesTech Inc | Matthew K. Szot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2020 | 846 | 0 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges